-
2
-
-
0024910321
-
Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization
-
Wu JS, Lewis H, Fine SL, Grover DA, Green WR. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 1989;9:292-301.
-
(1989)
Retina
, vol.9
, pp. 292-301
-
-
Wu, J.S.1
Lewis, H.2
Fine, S.L.3
Grover, D.A.4
Green, W.R.5
-
3
-
-
0018292173
-
Subretinal neovascularization with geographic (serpiginous) choroiditis
-
Jampol LM, Orth D, Daily MJ, Rabb MF. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683-689.
-
(1979)
Am J Ophthalmol
, vol.88
, pp. 683-689
-
-
Jampol, L.M.1
Orth, D.2
Daily, M.J.3
Rabb, M.F.4
-
4
-
-
0041356882
-
Serpiginous choroidopathy presenting as choroidal neovascularisation
-
Lee DK, Suhler EB, Augustin W, Buggage RR. Serpiginous choroidopathy presenting as choroidal neovascularisation. Br J Ophthalmol. 2003;87:1184-1185.
-
(2003)
Br J Ophthalmol
, vol.87
, pp. 1184-1185
-
-
Lee, D.K.1
Suhler, E.B.2
Augustin, W.3
Buggage, R.R.4
-
5
-
-
0036875646
-
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: Additional information regarding baseline lesion composition's impact on vision outcomes. TAP Report No. 3
-
Bressler NM, Arnold J, Benchaboune M, et al., for the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes. TAP Report No. 3. Arch Ophthalmol. 2002;120:1443-1454.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1443-1454
-
-
Bressler, N.M.1
Arnold, J.2
Benchaboune, M.3
-
6
-
-
0036822175
-
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 5
-
Blumenkranz MS, Bressler NM, Bressler SB, et al., for the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 5. Arch Ophthalmol. 2002;120:1307-1314.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1307-1314
-
-
Blumenkranz, M.S.1
Bressler, N.M.2
Bressler, S.B.3
-
7
-
-
1242319495
-
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Meta-analysis of 2-year safety results in three randomized clinical trials. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report No. 4
-
Azab M, Benchaboune M, Blinder KJ, et al., for the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, Verteporfin In Photodynamic (VIP) Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report No. 4. Retina. 2004;24:1-12.
-
(2004)
Retina
, vol.24
, pp. 1-12
-
-
Azab, M.1
Benchaboune, M.2
Blinder, K.J.3
-
8
-
-
0042168888
-
Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis
-
Navajas EV, Costa RA, Farah ME, Cardillo JA, Bonomo PP. Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis. Eye. 2003;17:563-566.
-
(2003)
Eye
, vol.17
, pp. 563-566
-
-
Navajas, E.V.1
Costa, R.A.2
Farah, M.E.3
Cardillo, J.A.4
Bonomo, P.P.5
-
9
-
-
0034532893
-
Optical coherence tomography features of idiopathic submacular choroidal neovascularization
-
Iida T, Hagimura N, Sato T, Kishi S. Optical coherence tomography features of idiopathic submacular choroidal neovascularization. Am J Ophthalmol. 2000;130:763-768.
-
(2000)
Am J Ophthalmol
, vol.130
, pp. 763-768
-
-
Iida, T.1
Hagimura, N.2
Sato, T.3
Kishi, S.4
-
10
-
-
0025805354
-
Triple agent immunosuppression in serpiginous choroiditis
-
Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944-952.
-
(1991)
Ophthalmology
, vol.98
, pp. 944-952
-
-
Hooper, P.L.1
Kaplan, H.J.2
-
11
-
-
0036342876
-
Successful treatment of serpiginous choroiditis with alkylating agents
-
Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109:1506-1513.
-
(2002)
Ophthalmology
, vol.109
, pp. 1506-1513
-
-
Akpek, E.K.1
Jabs, D.A.2
Tessler, H.H.3
Joondeph, B.C.4
Foster, C.S.5
-
12
-
-
0037678826
-
New treatments for serpiginous choroiditis
-
Akpek EK, Ilhan-Sarac O. New treatments for serpiginous choroiditis. Curr Opin Ophthalmol. 2003;14:128-131.
-
(2003)
Curr Opin Ophthalmol
, vol.14
, pp. 128-131
-
-
Akpek, E.K.1
Ilhan-Sarac, O.2
-
13
-
-
33749456708
-
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome
-
Oh WH, Yu HG, Chung H. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. J Korean Ophthalmol Soc. 2004;45:869-874.
-
(2004)
J Korean Ophthalmol Soc
, vol.45
, pp. 869-874
-
-
Oh, W.H.1
Yu, H.G.2
Chung, H.3
-
14
-
-
0042932600
-
Presumed tubercular serpiginouslike choroiditis: Clinical presentations and management
-
Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A. Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology. 2003;110:1744-1749.
-
(2003)
Ophthalmology
, vol.110
, pp. 1744-1749
-
-
Gupta, V.1
Gupta, A.2
Arora, S.3
Bambery, P.4
Dogra, M.R.5
Agarwal, A.6
|